Farmacia
Faculté
Hospital Universitario de Valme
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Valme (14)
2022
-
Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV
Journal of Multidisciplinary Healthcare, Vol. 15, pp. 2991-3003
2021
-
Association of ABO and Rh blood groups with obstetric outcomes in SARS-CoV-2 infected pregnancies: A prospective study with a multivariate analysis
European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 264, pp. 41-48
-
Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women
Viruses, Vol. 13, Núm. 1
-
The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis
BMC Pregnancy and Childbirth, Vol. 21, Núm. 1
2020
-
First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 410-416
2019
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
2018
-
Spanish Society of Hospital Pharmacy position paper on biosimilar medicines
Farmacia Hospitalaria, Vol. 42, Núm. 4, pp. 180-183
2017
-
Development of a risk stratification model for pharmaceutical care in HIV patients
Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 346-356
-
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: Discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1478-1487
2016
-
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530
2015
-
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1200-1209
2010
-
Consensus document on the use of biosimilar granulocyte-colony stimulating factor for the correction of neutropenia associated in cancer patients
Farmacia Hospitalaria, Vol. 34, Núm. SUPPL. 1, pp. 45-50
-
Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization
Journal of Microbiological Methods, Vol. 82, Núm. 1, pp. 98-101
2003
-
Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)
Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427